Site-Specific, Thiol-Mediated Conjugation of Fluorescent Probes to Cysteine-Modified Diabodies Targeting CD20 or HER2
- 18 November 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 19 (12), 2527-2534
- https://doi.org/10.1021/bc800113v
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecanCancer Gene Therapy, 2007
- Novel Single-Chain Fv′ Formats for the Generation of Immunoliposomes by Site-Directed CouplingBioconjugate Chemistry, 2007
- Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragmentNature Protocols, 2006
- Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv DimersClinical Cancer Research, 2006
- Multiplexed electrical detection of cancer markers with nanowire sensor arraysNature Biotechnology, 2005
- Optimizing Radiolabeled Engineered Anti-p185HER2 Antibody Fragments forIn vivoImagingCancer Research, 2005
- Quantitative Immuno-Positron Emission Tomography Imaging of HER2-Positive Tumor Xenografts with an Iodine-124 Labeled Anti-HER2 DiabodyCancer Research, 2005
- The Crystal Structure of an Anti-CEA scFv Diabody Assembled from T84.66 scFvs in VL-to-VH Orientation: Implications for Diabody FlexibilityJournal of Molecular Biology, 2003
- Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivityMolecular Immunology, 1995
- Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26–10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptidesProtein Engineering, Design and Selection, 1995